European competition authorities are expected to rule on the London Stock Exchange’s (LSE) US$27 billion takeover of data and analytics company Refinitiv “around the summer”, an LSE board member said on Tuesday, January 21.
LSE agreed in August to buy Refinitiv in a deal aimed at offering trading across regions and currencies and establishing the British company as a rival to Bloomberg, triggering speculation about the possible sale of assets to gain antitrust approval and to fund the deal.
“The Milan stock exchange is a strategic asset for LSE, it is not up for sale at the moment,” LSE director Raffaele Jerusalmi, who is also the chief executive of Borsa Italiana, said on the sideline of an event in Milan.
Jerusalmi said he did not see any issues in terms of overlap between bond platforms MTS and Tradeweb, which are owned, respectively, by LSE and Refinitiv.
The LSE-Refinitiv deal came just 10 months after a consortium led by US asset manager Blackstone completed a leverage buyout of Refinitiv from Thomson Reuters.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI